- West Island Brands (WIB) subsidiary West Island Culture has received the amendment to the company’s Health Canada license
- West Island is now authorized to process and sell Cannabis 2.0 products to provincial distributors and other authorized Canadian retail supply channels
- Oaziz Extracts and West Island are working together to develop and produce craft cannabis extracts to be sold to all authorized provincial retailers and distributors
- West Island Brands sells and distributes recreational and medical cannabis through a subsidiary, West Island Culture
- West Island Brands Inc. (WIB) opened trading at C$0.13
West Island Brands (WIB) subsidiary West Island Culture has received the amendment to the company’s Health Canada license.
West Island is now authorized to process and sell Cannabis 2.0 products to provincial distributors and other authorized Canadian retail supply channels.
West Island Culture continues to work closely with Montreal-based hashish and concentrates maker Oaziz Extracts Inc. (“Oaziz”). Oaziz and West Island are working together to develop and produce craft cannabis extracts to be sold to all authorized provincial retailers and distributors.
West Island COO, Meissam Hagh Panah, commented on the news.
“The demand for hash and resins and rosins is high, but supply is limited due to the small number of producers delivering a consistent and quality product. Even more popular are infused prerolls, which are the fastest-growing segment of the market. Through our partner Oaziz, West Island will bring premium Montreal-made hash offerings to the market. We will also bring infused prerolls and other concentrates to consumers eager for quality and innovation.”
West Island Brands sells and distributes recreational and medical cannabis through a subsidiary, West Island Culture. The firm operates out of its cultivation and processing facility in Dorval, Quebec. The company sells cannabis products under the OUEST and CITOYEN brands.
West Island Brands Inc. (WIB) opened trading at C$0.13.
